We Want Bigger 401(k) Matches - Even When We Shouldn't
Sprint Takes On T-Mobile With $60 Unlimited Data Plan
Hoarding: What's Going on With All That Stuff?
Market Wrap: Investors Take Cover as Ukraine Tensions Flare
View this photo on glassdoor.com
Deutsche Bank Raises Price Targets on Top Biotech and Health Care Stocks
Amgen reports positive Phase III results for AMG 416 to treat secondary hyperparathyroidism in CKD patients
Should I Buy or Invest in Space Technology, Research or Tourism Stocks
Amgen's Hyperparathyroidism Drug Hits All Endpoints in Phase 3
Analyst Upgrades: Microsoft Corporation, Gilead Sciences, Inc., and Amgen, Inc.
Amgen: Grappling With The Reality Of Patent Expiries
Amgen Reports Positive Phase 3 Results For Thyroid Drug AMG 416
Amgen announces positive Phase 3 results for AMG 416
Amgen (AMGN) Announces Positive Phase 3 Results for AMG 416 for CKD
4 Top Biotechs Expected to Beat Earnings Expectations